ArticleFrontiers in pharmacology2024

EM-transcriptomic signature predicts drug response in advanced stages of high-grade serous ovarian carcinoma based on ascites-derived primary cultures.

Diana-Roxana Constantinescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.